Clinical Trial Update: Advair Pediatric Once-Daily [Phase 3]

View source ↗

Summary

This entry notes the completion of a Phase 3 trial evaluating Advair pediatric once-daily for asthma. The snippet does not provide trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Advair (fluticasone propionate/salmeterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 3 | Status: COMPLETED